Tumour Antigen Choice - Key Publications

 

 

Publications are listed according to year, with the most recent first. Within each year, publications are listed in alphabetical order, based on the first author’s surname. Click on “Publication link” to access the publication on PubMed. Use the search box above to find particular publications based on author or terms in the title.

————————————————————————————————————————————————————-

  • CD8(+) T-cell immunity against cancer-testis antigens develops following allogeneic stem cell transplantation and reveals a potential mechanism for the graft-versus-leukemia effect.

    McLarnon A, Piper KP, Goodyear OC, Arrazi JM, Mahendra P, Cook M, Clark F, Pratt G, Craddock C, Moss PA.

    Haematologica. 2010 Sep;95(9):1572-8. doi: 10.3324/haematol.2009.019539. Epub 2010 May 11.

  • Cytotoxicity of the anti-CD22 immunotoxin HA22 (CAT-8015) against paediatric acute lymphoblastic leukaemia

    Mussai F, Campana D, Bhojwani D, Stetler-Stevenson M, Steinberg SM, Wayne AS, Pastan I.

    Br J Haematol. 2010 Aug;150(3):352-8.

  • Current status of GV1001 and other telomerase vaccination strategies in the treatment of cancer

    Shaw VE, Naisbitt DJ, Costello E, Greenhalf W, Park BK, Neoptolemos JP, Middleton GW.

    Expert Rev Vaccines. 2010 Sep;9(9):1007-16.

  • Chronic graft versus host disease is associated with an immune response to autologous human leukocyte antigen-derived peptides

    Smith HJ, Hanvesakul R, Morgan MD, Bentall A, Briggs D, Clark F, Pratt G, Moss P, Larch M, Ball S.

    Transplantation. 2010 Sep 15;90(5):555-63.

  • Ethnic variability in human leukocyte antigen-E haplotypes

    Antoun A, Jobson S, Cook M, Moss P, Briggs D.

    Tissue Antigens. 2009 Jan;73(1):39-45.

  • Preclinical development of T cell receptor gene therapy

    Bendle GM, Haanen JB, Schumacher TN.

    Curr Opin Immunol. 2009 Apr;21(2):209-14. doi: 10.1016/j.coi.2009.02.007. Epub 2009 Mar 25. Review.